ACTIVE

REPROBIOL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result71,4 k €-25,1 %over 1 year

Gross margin479,8 k €-5,0 %over 1 year

Equity1,5 M €-0,4 %over 1 year

Workforce5,8 ETP+3,6 %over 1 year

Identity

Source · BCE/KBO

REPROBIOL is a Private limited company incorporated in 2007. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Ouffet. It employs on average 5,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0886.862.189
Incorporation: 31/01/2007
Legal form: Private limited company
Registered office: Rue Pelé-Bois 20
4590 Ouffet · WallonieSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025
Average workforce: 5,8 ETP

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations+1

Joint committees (2)

Contacts

4 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	479,8 k €	-5.0%	505 k €	-16.4%	604,2 k €	+20.1%	503,1 k €	+66.9%	301,4 k €
EBITDA	197,6 k €	-6.6%	211,6 k €	-35.8%	329,5 k €	-1.3%	333,9 k €	+98.5%	168,2 k €
Operating result	98,6 k €	-22.3%	126,8 k €	-57.7%	300 k €	-1.3%	303,9 k €	+122%	136,8 k €
Net result	71,4 k €	-25.1%	95,3 k €	-58.6%	230,4 k €	+6.3%	216,8 k €	+112%	102,2 k €
Balance sheet
Equity	1,5 M €	-0.4%	1,5 M €	+5.1%	1,4 M €	+16.9%	1,2 M €	+18.8%	1 M €
Total assets	1,9 M €	+5.3%	1,8 M €	-14.1%	2,1 M €	+22.3%	1,7 M €	+4.3%	1,7 M €
Cash	650,3 k €	+89.7%	342,9 k €	-22.2%	440,7 k €	-22.9%	571,9 k €	+7.1%	534 k €
Debts	425,1 k €	+31.9%	322,4 k €	-53.8%	697 k €	+36.1%	512,1 k €	-19.7%	637,4 k €
Other
Workforce	5,8 ETP	+3.6%	5,6 ETP	+14.3%	4,9 ETP		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Benoit GLAUDE	Directorsince 21/12/2023Manager16/06/2016 → 2022 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jean-François Beckers	Manager29/09/2011 → 2013 accounts
Benoit Remy	Manager08/01/2007 → 29/09/2011
BIOPRODUCT CONSULT0506.777.785Represented by Jean-Francçois BECKERS	Manager2020 accounts

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/06/2026	16/06/2025	28/06/2024	28/07/2023	17/10/2022	30/12/2021
General meeting	18/06/2026	12/06/2025	20/06/2024	15/06/2023	16/06/2022	17/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	18/06/2026	20/06/2026	French	PDF
Abridged model	31/12/2024	12/06/2025	16/06/2025	French	PDF
Abridged model	31/12/2023	20/06/2024	28/06/2024	French	PDF
Micro model	31/12/2022	15/06/2023	28/07/2023	French	PDF
Micro model	31/12/2021	16/06/2022	17/10/2022	French	PDF
Micro model	31/12/2020	17/06/2021	30/12/2021	French	PDF
Micro model	31/12/2019	29/04/2020	30/05/2020	French	PDF
Micro model	31/12/2018	04/06/2019	28/08/2019	French	PDF
Micro model	31/12/2017	13/06/2018	28/08/2018	French	PDF
Micro model	31/12/2016	23/05/2017	09/06/2017	French	PDF
Abridged model	31/12/2015	16/06/2016	27/06/2016	French	PDF
Abridged model	31/12/2014	12/03/2015	02/06/2015	French	PDF
Abridged model	31/12/2013	24/04/2014	28/05/2014	French	PDF
Abridged model	31/12/2012	20/06/2013	27/06/2013	French	PDF
Abridged model	31/12/2011	28/06/2012	26/07/2012	French	PDF
Abridged model	31/12/2010	16/06/2011	29/06/2011	French	PDF
Abridged model	31/12/2009	17/06/2010	22/06/2010	French	PDF
Abridged model	31/12/2008	18/06/2009	22/06/2009	French	PDF
Abridged model	31/12/2007	19/06/2008	02/07/2008	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Benoit GLAUDE	Directorsince 21/12/2023Manager16/06/2016 → 2022 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jean-François Beckers	Manager29/09/2011 → 2013 accounts
Benoit Remy	Manager08/01/2007 → 29/09/2011
BIOPRODUCT CONSULT0506.777.785Represented by Jean-Francçois BECKERS	Manager2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates18/01/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates05/10/2016
DEMISSIONS, NOMINATIONS
PDF
Other09/08/2016
Modification des statuts
PDF
Mandates10/02/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates26/10/2011
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Other08/02/2007
« CONSTITUTION »
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Benoit GLAUDE

Jean-François Beckers

Benoit Remy

BIOPRODUCT CONSULT

20072008200920102011201220132014201520162017201820192020202120222023202420252026

REPROBIOL

Rue Pelé-Bois 20, 4590 Ouffet

DirectorManager

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Pelé-Bois 20, 4590 OuffetCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00179292

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
REPROBIOLCurrent	accounts 2007 → 2025	Accounts 2025 · 2026-00179292

Events

2025
Annual accounts 202571,4 k €↓
2024
Annual accounts 202495,3 k €↓
2023
Annual accounts 2023230,4 k €↑
2022
Annual accounts 2022216,8 k €↑
2021
Annual accounts 2021102,2 k €↑
2020
Annual accounts 2020-24,9 k €↓
2019
Annual accounts 2019-7,4 k €↓
2018
Annual accounts 201827,5 k €↓
2017
Annual accounts 2017106 k €↑
2016
Annual accounts 2016-68,1 k €↓
2015
Annual accounts 201556,2 k €↓
2014
Annual accounts 2014127,5 k €↓
2013
Annual accounts 2013170,7 k €↑
2012
Annual accounts 201276,7 k €↑
2011
Annual accounts 201168,6 k €↑
2010
Annual accounts 201049,2 k €↓
2009
Annual accounts 2009102,6 k €↓
2008
Annual accounts 2008111,7 k €↑
2007
Annual accounts 2007101,4 k €
31/01/2007
IncorporationPrivate limited company

REPROBIOL

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events